General Information of Drug (ID: DMY6AHK)

Drug Name
RiMO-301
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
TTD ID
D61LJZ

References

1 ClinicalTrials.gov (NCT03444714) Phase I Study of RiMO-301 With Radiation in Advanced Tumors. U.S. National Institutes of Health.